|
ZBTB26 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.414950E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.339900E-02 |
| Normal-vs-Stage2 |
7.451000E-01 |
| Normal-vs-Stage3 |
3.537700E-02 |
| Normal-vs-Stage4 |
7.261000E-01 |
| Stage1-vs-Stage2 |
1.715180E-01 |
| Stage1-vs-Stage3 |
3.812200E-01 |
| Stage1-vs-Stage4 |
8.721000E-01 |
| Stage2-vs-Stage3 |
9.715900E-02 |
| Stage2-vs-Stage4 |
6.036000E-01 |
| Stage3-vs-Stage4 |
6.063600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.725780E-01 |
| Normal-vs-AfricanAmerican |
3.257200E-01 |
| Normal-vs-Asian |
6.115100E-03 |
| Caucasian-vs-AfricanAmerican |
9.695800E-01 |
| Caucasian-vs-Asian |
2.415800E-01 |
| AfricanAmerican-vs-Asian |
2.221800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.996100E-02 |
| Normal-vs-Female |
8.257000E-01 |
| Male-vs-Female |
7.998400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.049430E-01 |
| Normal-vs-Extreme_Weight |
1.791960E-02 |
| Normal-vs-Obese |
9.790600E-01 |
| Normal-vs-Extreme_Obese |
4.546000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.670400E-01 |
| Normal_Weight-vs-Obese |
1.674370E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.722800E-01 |
| Extreme_Weight-vs-Obese |
5.144200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.441000E-01 |
| Obese-vs-Extreme_Obese |
6.710000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.321900E-02 |
| Normal-vs-Age(41-60Yrs) |
6.440200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.762290E-02 |
| Normal-vs-Age(81-100Yrs) |
2.160200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.459900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.552600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.543600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.916800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.302600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.304400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.336420E-01 |
| Normal-VS-Type2 PRCC |
7.488400E-02 |
| Normal-VS-KIRP CIMP |
1.330850E-01 |
| Normal-VS-Unclassified PRCC |
6.369400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.058200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.069400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.351610E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.777200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.220640E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.037390E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.023560E-03 |
| Normal-vs-N1 |
9.868600E-01 |
| Normal-vs-N2 |
1.388810E-01 |
| N0-vs-N1 |
1.092600E-01 |
| N0-vs-N2 |
9.105800E-01 |
| N1-vs-N2 |
5.299800E-01 |
|
|
